AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 264 filers reported holding AVANOS MED INC in Q2 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $251,294 | -33.5% | 12,428 | -16.0% | 0.00% | – |
Q2 2023 | $378,135 | -55.6% | 14,794 | -48.3% | 0.00% | – |
Q1 2023 | $851,308 | +52.0% | 28,625 | +11.4% | 0.00% | – |
Q3 2022 | $560,000 | +128.6% | 25,707 | +251.9% | 0.00% | – |
Q1 2022 | $245,000 | -61.8% | 7,305 | -60.6% | 0.00% | – |
Q4 2021 | $642,000 | +189.2% | 18,518 | +203.6% | 0.00% | – |
Q2 2021 | $222,000 | -89.1% | 6,100 | -86.3% | 0.00% | – |
Q4 2020 | $2,044,000 | +325.8% | 44,550 | +208.2% | 0.00% | – |
Q3 2020 | $480,000 | +0.8% | 14,453 | -10.8% | 0.00% | – |
Q2 2020 | $476,000 | -73.8% | 16,209 | -76.0% | 0.00% | – |
Q1 2020 | $1,816,000 | +28.1% | 67,447 | +60.4% | 0.00% | – |
Q4 2019 | $1,418,000 | +3.7% | 42,058 | +15.2% | 0.00% | – |
Q3 2019 | $1,368,000 | -68.5% | 36,523 | -63.3% | 0.00% | – |
Q2 2019 | $4,345,000 | +348.9% | 99,590 | +338.7% | 0.00% | – |
Q1 2019 | $968,000 | +35.0% | 22,700 | +41.9% | 0.00% | – |
Q4 2018 | $717,000 | -89.2% | 16,000 | -83.5% | 0.00% | -100.0% |
Q3 2018 | $6,631,000 | – | 96,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |